Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Medicare Part D now covers select weight loss medications for eligible beneficiaries, a significant change from the historical exclusion of anti-obesity drugs
The effects of GLP-1 receptor agonists on body composition in patients with type 2 diabetes, overweight or obesity: A meta-analysis of randomized controlled trials
You need to have an open conversation with your healthcare provider about your medical history, weight loss goals, and any concerns you might have
This approach is especially valuable for patients who experienced severe initial side effects or who plan long-term weight management without medication
Semaglutide hits GLP-1, tirzepatide adds GIP, retatrutide adds glucagon
They can lower blood pressure, reduce inflammation, and improve cholesterol, and they may slow the progression of kidney damage
